Literature DB >> 1866957

Reversing disability of irreversible lung disease.

B L Tiep1.   

Abstract

Pulmonary rehabilitation is a comprehensive multifaceted team approach for integrating medical management, coping skills, self-management techniques, and exercise reconditioning. It provides patients with chronic lung disease the ability to adapt and live full and nearly normal lives. These changes are possible because the overall disability includes significant reversible components: Patients have bronchospasm, infection, and cor pulmonale; they respond to progressively impaired lungs by progressive inactivity, leading to physical deconditioning. Both factors contribute to dyspnea. Because patients naturally fear dyspnea, they panic easily. During panic, their work of breathing may increase and respiratory failure may result. Pulmonary rehabilitation provides good medical management; provides exercises to increase strength, endurance, and tolerance to dyspnea; and trains patients in panic control. These programs have not been shown to lengthen life span or improve static lung function. They increase exercise performance and render patients functional, independent, and subject to fewer hospital admissions. Pulmonary rehabilitation is the only approach to chronic lung disease short of lung transplantation that improves the long-term outlook for these patients.

Entities:  

Mesh:

Year:  1991        PMID: 1866957      PMCID: PMC1002840     

Source DB:  PubMed          Journal:  West J Med        ISSN: 0093-0415


  15 in total

1.  THE EFFECT OF AIR FLOW AND ORAL PRESSURE ON THE MECHANICS OF BREATHING IN PATIENTS WITH ASTHMA AND EMPHYSEMA.

Authors:  R W SCHMIDT; K WASSERMAN; G A LILLINGTON
Journal:  Am Rev Respir Dis       Date:  1964-10

2.  Outpatient pulmonary rehabilitation. A new lease on life.

Authors:  M Burns
Journal:  Postgrad Med       Date:  1989-11-01       Impact factor: 3.840

3.  Upper extremity exercise training in chronic obstructive pulmonary disease.

Authors:  A L Ries; B Ellis; R W Hawkins
Journal:  Chest       Date:  1988-04       Impact factor: 9.410

Review 4.  Long-term home oxygen therapy.

Authors:  B L Tiep
Journal:  Clin Chest Med       Date:  1990-09       Impact factor: 2.878

5.  Effect of pursed lips expiration on the pulmonary pressure-flow relationship in obstructive lung disease.

Authors:  R H Ingram; D P Schilder
Journal:  Am Rev Respir Dis       Date:  1967-09

6.  Increased exercise performance in patients with severe COPD following inspiratory resistive training.

Authors:  L J Sonne; J A Davis
Journal:  Chest       Date:  1982-04       Impact factor: 9.410

7.  Pursed lips breathing training using ear oximetry.

Authors:  B L Tiep; M Burns; D Kao; R Madison; J Herrera
Journal:  Chest       Date:  1986-08       Impact factor: 9.410

8.  Oxygen conservation and oxygen-conserving devices in chronic lung disease. A review.

Authors:  B L Tiep; M I Lewis
Journal:  Chest       Date:  1987-08       Impact factor: 9.410

9.  Effect of InspirEase on the deposition of metered-dose aerosols in the human respiratory tract.

Authors:  S P Newman; G Woodman; S W Clarke; M A Sackner
Journal:  Chest       Date:  1986-04       Impact factor: 9.410

10.  Inspiratory muscle training with a pressure threshold breathing device in patients with chronic obstructive pulmonary disease.

Authors:  J L Larson; M J Kim; J T Sharp; D A Larson
Journal:  Am Rev Respir Dis       Date:  1988-09
View more
  3 in total

1.  The effects of therapist breathing style on subject's inhalation volumes.

Authors:  V Tibbetts; E Peper
Journal:  Biofeedback Self Regul       Date:  1993-06

Review 2.  The epidemiology and therapy of airflow limitation in the elderly.

Authors:  L Dow
Journal:  Drugs Aging       Date:  1992 Nov-Dec       Impact factor: 3.923

3.  Barriers and motivational factors towards physical activity in daily life living with COPD - an interview based pilot study.

Authors:  Elisabeth Bomholt Østergaard; Sajitha Sophia Sritharan; Anne Dal Kristiansen; Pernille Maja Thomsen; Anders Løkke
Journal:  Eur Clin Respir J       Date:  2018-07-06
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.